Prevtyn Beta News Today

VidPrevtyn Beta, the COVID-19 vaccine developed by Sanofi, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).

Sanofi's SARS-CoV-2 spike protein (B.1.351 strain) vaccine, (VidPrevtyn Beta) is the first and only Beta variant protein-based COVID-19 booster approved in Great Britain and the European Union

By Jean-Stphane Brosse and Tassilo Hummel PARIS (Reuters) - France's Haute Autorite de Sante public health body advised the government not to use Valn...

EMA’s human medicines committee (CHMP) has recommended authorising the COVID-19 vaccine VidPrevtyn Beta as a booster in adults previously...

EMA's human medicines committee's November meeting recommended approval of four medicines, including a biosimilar for osteoporosis.

Investegate announcements from Sanofi - Aventis Groupe, Press Release: Sanofi and GSK’s next-generation COVID-19 booster vaccine VidPrevtyn® Beta approved by the European Commission

Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by the European Commission First and only next-generation protein-based adjuvanted COVID-19 booster approved

Investegate announcements from GSK PLC, Sanofi-GSK COVID booster vaccine approved by EU